Q4 2019 13F Holders as of 31 Dec 2019
-
Type / Class
-
Equity / Common / Ordinary Stock
-
Total 13F shares
-
4,398,834
-
Share change
-
+175,132
-
Total reported value
-
$384,835,517
-
Price per share
-
$87.93
-
Number of holders
-
93
-
Value change
-
+$18,180,444
-
Number of buys
-
39
-
Number of sells
-
47
Institutional Holders of Taro Pharmaceutical Industries Ltd - Common / Ordinary Stock (TARO) as of Q4 2019
As of 31 Dec 2019,
Taro Pharmaceutical Industries Ltd - Common / Ordinary Stock (TARO) was held by
93 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
4,398,834 shares.
The largest 10 holders included
FMR LLC, RENAISSANCE TECHNOLOGIES LLC, DIMENSIONAL FUND ADVISORS LP, Krensavage Asset Management, LLC, ACADIAN ASSET MANAGEMENT LLC, APG Asset Management N.V., NORGES BANK, Invesco Ltd., D. E. Shaw & Co., Inc., and ROYAL BANK OF CANADA.
This page lists
93
institutional shareholders reporting positions in this security
for the Q4 2019 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.